Shanghai Henlius Biotech Reports the First Patient Dosing of HLX15 (biosimilar, daratumumab) in P-I Clinical Trial for Multiple My...
Shots: The first patient has been dosed in the P-I trial that consists of 2 parts...
Amylyx Reports the Completion of Patient Enrollment in P-III Trial (PHOENIX) of AMX0035 for Amyotrophic Lateral Sclerosis
Shots: The company has completed the patient enrolment in the P-III trial (PHOENIX...
Aulos Bioscience Reports the First Patient Dosing of AU-007 in P-I/II Clinical Trial for the Treatment of Solid Tumors
Shots: The 1st patient has been dosed in the P-I/II trial evaluating AU-007 at 4 l...
Sciwind Biosciences Initiates the Patient Dosing of Ecnoglutide (XW003) in P-III Clinical Trials for the Treatment of Type 2 Diabe...
Shots: The first P-III study evaluates ecnoglutide (qw, SC) in ~210 treatment-na&i...
Daiichi Sankyo Reports the First Patient Dosing of Datopotamab Deruxtecan in P-III Trial (TROPION-Lung07) for Metastatic Non-Small...
Shots: The first patient has been dosed in the P-III trial (TROPION-Lung07) evalua...
Janssen Reports P-III Study (CARTITUDE-4) Results of Carvykti (cilta-cel) for the Treatment of Multiple Myeloma
Shots: The P-III study (CARTITUDE-4) that evaluated the efficacy & safety of C...
